Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$72.81 - $156.91 $149,551 - $322,293
-2,054 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$112.21 - $151.95 $230,479 - $312,105
2,054 New
2,054 $312,000
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $20.5 Million - $28.7 Million
-177,445 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$71.74 - $153.69 $12.7 Million - $27.3 Million
177,445 New
177,445 $23.5 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.